74 related articles for article (PubMed ID: 35081341)
1. Activation of the cGAS-STING pathway by viral dsDNA leading to M1 polarization of macrophages mediates antiviral activity against hepatitis B virus.
Zong Q; Zhang H; Liu F; Li J; Liu Q; Duan Z; Duan W; Ruan M; Zhang J; Liu Y; Zhou Q; Wang Q
Immunobiology; 2024 May; 229(3):152810. PubMed ID: 38772101
[TBL] [Abstract][Full Text] [Related]
2. Increased GABA signaling in liver macrophage promotes HBV replication in HBV-carrier mice.
Chen Y; Yin Z; Zhang X; Zhao Y; Liu T; Lu WY; Wang S
Virus Res; 2024 Jun; 344():199366. PubMed ID: 38548137
[TBL] [Abstract][Full Text] [Related]
3. HBV suppresses macrophage immune responses by impairing the TCA cycle through the induction of CS/PDHC hyperacetylation.
Bei J; Chen Y; Zhang Q; Wang X; Lin L; Huang J; Huang W; Cai M; Cai W; Guo Y; Zhu K
Hepatol Commun; 2023 Nov; 7(11):. PubMed ID: 37820280
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus e antigen induces atypical metabolism and differentially regulates programmed cell deaths of macrophages.
Li Y; Wu C; Lee J; Ning Q; Lim J; Eoh H; Wang S; Hurrell BP; Akbari O; Ou JJ
PLoS Pathog; 2024 Mar; 20(3):e1012079. PubMed ID: 38466743
[TBL] [Abstract][Full Text] [Related]
5. The novel mechanism facilitating chronic hepatitis B infection: immunometabolism and epigenetic modification reprogramming.
Wang Z; Liu N; Yang Y; Tu Z
Front Immunol; 2024; 15():1349867. PubMed ID: 38288308
[TBL] [Abstract][Full Text] [Related]
6. Inflammaging and fatty acid oxidation in monocytes and macrophages.
Kruglov V; Jang IH; Camell CD
Immunometabolism (Cobham); 2024 Jan; 6(1):e00038. PubMed ID: 38249577
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial Oxidative Phosphorylation in Viral Infections.
Purandare N; Ghosalkar E; Grossman LI; Aras S
Viruses; 2023 Dec; 15(12):. PubMed ID: 38140621
[TBL] [Abstract][Full Text] [Related]
8. Regulation of Mitochondrial Metabolism by Hepatitis B Virus.
Li Y; Ou JJ
Viruses; 2023 Nov; 15(12):. PubMed ID: 38140600
[TBL] [Abstract][Full Text] [Related]
9. The Role of Interleukins in HBV Infection: A Narrative Review.
Dimitriadis K; Katelani S; Pappa M; Fragkoulis GE; Androutsakos T
J Pers Med; 2023 Nov; 13(12):. PubMed ID: 38138902
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome Proliferator-Activated Receptor-Targeted Therapies: Challenges upon Infectious Diseases.
Kim IS; Silwal P; Jo EK
Cells; 2023 Feb; 12(4):. PubMed ID: 36831317
[TBL] [Abstract][Full Text] [Related]
11. IL-1RAP, a Key Therapeutic Target in Cancer.
Frenay J; Bellaye PS; Oudot A; Helbling A; Petitot C; Ferrand C; Collin B; Dias AMM
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499246
[TBL] [Abstract][Full Text] [Related]
12. Promiscuous Inflammasomes: The False Dichotomy of RNA/DNA Virus-Induced Inflammasome Activation and Pyroptosis.
Wallace HL; Russell RS
Viruses; 2022 Sep; 14(10):. PubMed ID: 36298668
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the interplay between hepatitis B virus-positive hepatocytes and Kupffer cells
Li Y; Lee J; Helou DG; Akbari O; Ou JJ
STAR Protoc; 2022 Jun; 3(2):101364. PubMed ID: 35573478
[TBL] [Abstract][Full Text] [Related]
14. A novel multifunctional anti-PD-L1-CD16a-IL15 induces potent cancer cell killing in PD-L1-positive tumour cells.
Li Y; Wu L; Liu Y; Ma S; Huang B; Feng X; Wang H
Transl Oncol; 2022 Jul; 21():101424. PubMed ID: 35477065
[TBL] [Abstract][Full Text] [Related]
15. Phytomedicines to Target Hepatitis B Virus DNA Replication: Current Limitations and Future Approaches.
Sadiea RZ; Sultana S; Chaki BM; Islam T; Dash S; Akter S; Islam MS; Kazi T; Nagata A; Spagnuolo R; Mancina RM; Hossain MG
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163539
[TBL] [Abstract][Full Text] [Related]
16. Macrophages activated by hepatitis B virus have distinct metabolic profiles and suppress the virus via IL-1β to downregulate PPARα and FOXO3.
Li Y; Zhu Y; Feng S; Ishida Y; Chiu TP; Saito T; Wang S; Ann DK; Ou JJ
Cell Rep; 2022 Jan; 38(4):110284. PubMed ID: 35081341
[TBL] [Abstract][Full Text] [Related]
17. Interferon-induced polarization of M1 macrophages mediates antiviral activity against the hepatitis B virus via the hepcidin-ferroportin axis.
Liu Q; Li J; Zong Q; Duan Z; Liu F; Duan W; Ruan M; Zhang H; Liu Y; Zhou Q; Wang Q
Int Immunopharmacol; 2024 Jun; 134():112219. PubMed ID: 38733823
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
